FDA Creates New Advisory Committee for Evaluation of Genetic Metabolic Disease Treatments

Today, the U.S. Food and Drug Administration announced it is creating a new advisory committee related to potential treatments for genetic metabolic diseases.

https://www.fda.gov/news-events/press-announcements/fda-creates-new-advisory-committee-evaluation-genetic-metabolic-disease-treatments

Related articles

View all the news and events
Conference

5th MENA Congress for Rare Diseases 2026

 From April 9, 2026 to April 11, 2026

The 5th MENA Congress for Rare Diseases 2026 will take place from 9 to 11 April 2026 in Abu Dhabi, United Arab Emirates. This landmark meeting …